# Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease

> **NCT02501876** · — · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 202 (actual)

## Conditions studied

- Alzheimer´s Disease
- Diabetes Mellitus Type 2

## Interventions

- **OTHER:** There is a retrospectiv observational study. No intervention

## Key facts

- **NCT ID:** NCT02501876
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-09
- **Final completion:** 2016-05
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02501876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02501876, "Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02501876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*